Evaluation of iPRF With Vit.D As an Adjunct to Non-Surgical Therapy in the Treatment of Stage III Periodontitis
NCT ID: NCT06570200
Last Updated: 2024-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2
45 participants
INTERVENTIONAL
2024-10-31
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of iPRF With Vitamin C in StageII Grade A Periodontitis
NCT05129267
The Proposed Study Aims to Investigate the Impact of Adjunctive Vitamin D Gel Application on Gingival Crevicular Fluid Levels of Alkaline Phosphatase and Interleukin-8 in Periodontitis Patients Undergoing Phase 1 Periodontal Therapy. By Elucidating the Molecular Mechanisms Underlying the Therapeutic
NCT06669026
Evaluation of The Periodontal Parameters Following Non-Surgical Periodontal Therapy With and Without Adjunctive Use of Injectable Platelet Rich Fibrin: A Randomized Controlled Clinical Trial
NCT07090265
Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients
NCT06654063
Injectable Platelet Rich Fibrin in Periodontal Treatment
NCT06814418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First group \>\> will be treated with professional mechanical plaque removal (PMPR) only.
second group \>\> will be treated with PMPR + locally applied iPRF.
Third group \>\> will be treated with PMPR + locally applied iPRF + vitamin D.
Then the results will be compared after 6 months of the treatment (clinically and radiographically).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PMPR only
scaling and root planing only will be made for group 1 (control group)
PMPR only
scaling and root planing only will be done for the periodontal pocket for the control group
PMPR + iPRF
scaling and root planing plus locally applied iPRF in the periodontal pocket will be made for test group 1.
PMPR+iPRF
locally applied iPRF in the periodontal pocket
PMPR + iPRF + Vit.D
scaling and root planing plus locally applied iPRF and vitamin D in the periodontal pocket will be made for test group 2.
vitamin D will be obtained from a commercial product in the Egyptian pharmacies called (Devarol S) in the form of injectable ampoules containing 200000 IU of cholecalciferol (2.5 mg/ml)
PMPR+iPRF+Vit.D
locally applied iPRF plus vitamin D in the periodontal pocket
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PMPR+iPRF
locally applied iPRF in the periodontal pocket
PMPR+iPRF+Vit.D
locally applied iPRF plus vitamin D in the periodontal pocket
PMPR only
scaling and root planing only will be done for the periodontal pocket for the control group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Adult patients ˃ 18 years old.
3. Patients with Stage III periodontitis.
4. Patients accept 3-month follow-up period (cooperative patients).
5. Patients provide an informed consent.
Exclusion Criteria
2. Extensive interproximal restorations.
3. Periodontal therapy within the last 12 months.
4. Having undergone surgical periodontal therapy or undergoing orthodontic treatment.
5. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis.
6. The use of antibiotics or anti-inflammatory drugs 3-month prior to the procedure and till the end of 6-month of follow-up.
7. Smokers.
8. Pregnant females.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed hamed fattouh hamed
dentist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof.Dr Manal Hosny, professor
Role: STUDY_DIRECTOR
Cairo University
Prof.Dr Karim Fawzy, Professor
Role: STUDY_DIRECTOR
Cairo University
Prof.Dr Luigi Nibali, Professor
Role: STUDY_DIRECTOR
King's College London
Dr.Manar T El-zanaty, Doctorate
Role: STUDY_DIRECTOR
Cairo University
Ahmed Fattouh, Bachelor
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Torumtay Cin G, Lektemur Alpan A, Cevik O. Efficacy of injectable platelet-rich fibrin on clinical and biochemical parameters in non-surgical periodontal treatment: a split-mouth randomized controlled trial. Clin Oral Investig. 2023 Dec 28;28(1):46. doi: 10.1007/s00784-023-05447-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CairoU50022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.